Estimating the population impact of screening strategies for identifying and treating people at high risk of cardiovascular disease: modelling study
about
Systematic versus opportunistic risk assessment for the primary prevention of cardiovascular diseaseSystematic versus opportunistic risk assessment for the primary prevention of cardiovascular diseaseA comparative assessment of non-laboratory-based versus commonly used laboratory-based cardiovascular disease risk scores in the NHANES III populationPostcode lotteries in public health--the NHS Health Checks Programme in North West London.2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by represScreening for increased cardiometabolic risk in primary care: a systematic review.Diversity and ambivalence in general practitioners' attitudes towards preventive health checks - a qualitative study.Mixed methods evaluation of targeted case finding for cardiovascular disease prevention using a stepped wedged cluster RCT.Cardiovascular screening in general practice in a low SES area.Comparing the effectiveness of two cardiovascular prevention programmes for highly educated professionals in general practice: a randomised clinical trialImpact and cost of a 2-week community-based screening and awareness program for diabetes and cardiovascular risk factors in a Swiss canton.Risk assessment tools for identifying individuals at risk of developing type 2 diabetes.The effectiveness of screening for diabetes and cardiovascular disease risk factors in a community pharmacy settingPopulation impact of a high cardiovascular risk management program delivered by village doctors in rural China: design and rationale of a large, cluster-randomized controlled trial.The Envy of Scholars: Applying the Lessons of the Framingham Heart Study to the Prevention of Chronic Kidney DiseaseFamilial clustering of risk factors for cardiovascular disease among first-degree relatives of patients with chronic kidney disease in a sub-Saharan African population.Impact of age and sex on primary preventive treatment for cardiovascular disease in the West Midlands, UK: cross sectional studyComparison of Cardiovascular Risk Screening Methods and Mortality Data among Hungarian Primary Care Population: Preliminary Results of the First Government-Financed Managed Care Program.Which Measures of Health Status Assessment are the Most Significant in Organized Cohorts with Low Current Cardiovascular Risk? The Screening Study of Penitentiary Staff in Saratov Region, Russia.Identification of effective screening strategies for cardiovascular disease prevention in a developing country: using cardiovascular risk-estimation and risk-reduction tools for policy recommendations.Estimating the potential population impact of stepwise screening strategies for identifying and treating individuals at high risk of Type 2 diabetes: a modelling study.Participation in preventive health check-ups among 19,351 women in Germany.Who needs laboratories and who needs statins?: comparative and cost-effectiveness analyses of non-laboratory-based, laboratory-based, and staged primary cardiovascular disease screening guidelinesThe Role of Text Messaging in Cardiovascular Risk Factor Optimization.Implementation of NHS Health Checks in general practice: variation in delivery between practices and practitioners.Overweight can be used as a tool to guide case-finding for cardiovascular risk assessment.Erectile dysfunction may improve by blood pressure control in patients with high-risk hypertension.Screening blood donors for diabetes: analysis of use, accuracy, and cost.Ethnic differences in the cost-effectiveness of targeted and mass screening for high cardiovascular risk in the UK: cross-sectional study.Critical research gaps and recommendations to inform research prioritisation for more effective prevention and improved outcomes in colorectal cancer.Cost-Effectiveness of Cardiovascular Screening in Patients With Rheumatoid Arthritis.The potential for a two-stage diabetes risk algorithm combining non-laboratory-based scores with subsequent routine non-fasting blood tests: results from prospective studies in older men and women.A comparative analysis of three widely used lipid management guidelines in the EPIC-Norfolk cohort.Treatment gaps and potential cardiovascular risk reduction from expanded statin use in the US and England.Validity of self-assessed waist circumference in a multi-ethnic UK population.2016 European Guidelines on cardiovascular disease prevention in clinical practice
P2860
Q24186332-2984C806-94A3-48DE-9195-787364D659EDQ24201138-39177E67-A94B-4069-8A2C-C2DB222ADC72Q33927100-D5C5CE4A-F5A5-455A-A587-FDBD6C5F4144Q34034158-3E89D344-2FDB-4A21-8D54-C09D4E2152CFQ34046881-DA302577-A77F-44A9-8F30-7289CDED18D0Q34237493-56ABE667-DC5A-49C6-9BA6-45687505BB44Q34297718-9DC440B4-D280-431D-90DA-874C98020C01Q34458378-2A28AA71-0384-408E-8D3F-7F666D3B60FCQ34507659-A7FDF1F6-6E82-4BA4-A4D7-58EB496A93B1Q34750530-B33AB76A-3C41-42B0-9E80-1CA2FFB47B12Q35092371-0F25CDDD-9609-41CD-BCAA-89325E6615FAQ35095114-68400687-439C-4046-B62D-A4B207B390D5Q35137431-DCCCB2E9-335F-4B88-A23D-A8D6328F56FFQ35144775-AF2DCB2E-32E2-4433-9A8D-9529EEF669C8Q35914820-B811A1B9-1E55-404B-950F-358A0D336111Q35990779-52E70912-742F-434E-8E8E-E7F918592F39Q36091989-B19A2ACB-48B2-4BD5-BD13-3472A40C12B3Q36137697-5A6A1468-B056-44EE-B7FB-D43F9FFE3168Q36688777-D0F734F6-27D2-4182-9622-556F0F4AE778Q36689809-61EDE136-9151-43AA-9E19-1986D739B540Q37271291-FEFE8BB3-7920-4C1C-9CB6-3277839B7399Q37643116-4FB6D9CD-FB4A-481E-B60A-FB448CCE9145Q37677821-0DE46A48-9E6A-44CE-948B-07F164EA5E62Q38768588-12366BF6-CEAF-4D28-B174-0D83D2B9C8B9Q40369154-35D18EA3-4418-468B-B918-6A93F2410A1BQ41206092-5362CD82-B54C-4961-832D-0808B18A1470Q42805340-D3A6FB41-8C3A-4EE5-92FB-FE959B66A0ADQ44851712-B7B6E3DB-7D70-4849-8159-69C694D6C1B0Q46632963-EEEA0FA6-B1F9-4902-95B5-99097FBC5944Q47321577-4BABEDA3-C5BC-4A5D-9246-EED3D5DB0D10Q47802987-E8603278-836E-4531-A1E2-A70962E3B81DQ51384231-6D580249-683E-4DE0-B410-A7F6545CFFD5Q53660419-35D91255-49F2-4A83-AAE7-4450E7226BDCQ53678430-2031BC7C-4B8C-475E-A380-E0699850023CQ54684979-2A262EAF-38FE-4E98-89B5-442FBFBBE08EQ56991525-13F1351F-A577-49C6-A99E-D083DE20BA60
P2860
Estimating the population impact of screening strategies for identifying and treating people at high risk of cardiovascular disease: modelling study
description
2010 nî lūn-bûn
@nan
2010 թուականին հրատարակուած գիտական յօդուած
@hyw
2010 թվականին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Estimating the population impa ...... cular disease: modelling study
@ast
Estimating the population impa ...... cular disease: modelling study
@en
Estimating the population impa ...... cular disease: modelling study
@nl
type
label
Estimating the population impa ...... cular disease: modelling study
@ast
Estimating the population impa ...... cular disease: modelling study
@en
Estimating the population impa ...... cular disease: modelling study
@nl
prefLabel
Estimating the population impa ...... cular disease: modelling study
@ast
Estimating the population impa ...... cular disease: modelling study
@en
Estimating the population impa ...... cular disease: modelling study
@nl
P2860
P50
P356
P1433
P1476
Estimating the population impa ...... cular disease: modelling study
@en
P2860
P356
10.1136/BMJ.C1693
P407
P433
P577
2010-01-01T00:00:00Z